{"transactions":[{"id":2068475,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":121030,"kind":"person","name":"Castle John C.","position":1,"cik":"0001855641","reported_name":"Castle John C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Data Scientist"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-04T16:30:57.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":78500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on January 1, 2024, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":78500,"derivative":{"exercise_price":7.78,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":78500},"source":{"system":"sec-edgar","filing":"0001209191-23-000953","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855641/000120919123000953/doc4.xml","form_type":"4"}},{"id":2361303,"issuer":{"id":4828,"kind":"organization","name":"Monte Rosa Therapeutics, Inc.","symbol":"GLUE"},"owners":[{"id":121030,"kind":"person","name":"Castle John C.","position":1,"cik":"0001855641","reported_name":"Castle John C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Data Scientist"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-02T18:42:11.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":53700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":53700,"derivative":{"exercise_price":13.41,"expiration_date":"2032-02-29","underlying":"Common Stock","underlying_shares":53700},"source":{"system":"sec-edgar","filing":"0000899243-22-008694","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855641/000089924322008694/doc4.xml","form_type":"4"}}]}